Innovating Works

2CUREX GMBH

A stranger
MicroCaT: Micro tumor Guided Cancer Therapy Selection MicroCaT 2CUREX GMBH participó en un H2020: H2020-SMEInst-2016-2017 Every year around 350.000 patients in the EU are newly diagnosed with colorectal cancer (CRC). Although € 1.4 Billion are spent on CRC drug...
2018-01-20 - 2021-03-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.